Skip to main content
Premium Trial:

Request an Annual Quote

Steve Lombardi, Stan Lapidus, Michael Olex, Hagan Bayley, Dan Branton, Jene Golovchenko, David Deamer, Mark Akeson, Amit Meller

Steve Lombardi will replace Stan Lapidus as CEO of Helicos BioSciences, the company said this week. Lapidus will continue as chairman of the board.
Lombardi joined Helicos in June 2006 as senior vice president of sales and marketing and was later promoted to executive vice president and chief operating officer. In October 2007 he was named president and chief operating officer.
He will retain the position of president in his new role as CEO.
Prior to joining Helicos, Lombardi was vice president of Applied Biosystems' DNA-sequencing and genetic-analysis business unit, and a senior vice president at Affymetrix.

Michael Olex has been appointed vice president of system development at RainDance Technologies. Olex previously was VP of manufacturing at BioTrove, senior VP at US Genomics, and director of business projects at Applied Biosystems.
Olex will focus on the first application for the company’s microdroplet experimental platform: a sequence-enrichment application for targeted genomic sequencing that will be launched later this year.

Oxford Nanopore Technologies has created a technical advisory board comprising Hagan Bayley, a professor at the University of Oxford and a company founder; Dan Branton and Jene Golovchenko of Harvard University; David Deamer and Mark Akeson of the University of California, Santa Cruz; and Amit Meller of Boston University.
The company said that the board will provide “unparalleled technical expertise” in the development its nanopore sequencing technology.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.